MEA In Vivo Preclinical Brain Imaging Devices Market - Industry Trends and Forecast to 2033

Description

List of Tables

The Middle East and Africa in vivo preclinical brain imaging devices market is expected to reach USD 23,827.66 thousand by 2030 from USD 17,930.19 thousand in 2022, growing at a CAGR of 3.7% in the forecast period of 2023 to 2030.

Market Segmentation

Middle East and Africa In Vivo Preclinical Brain Imaging Devices Market, By Imaging Modality Type (MRI, PET/SPECT, CT, Optical Miniscopes, 2Photon Confocal, US, NIR Fluorescence, OCT, Bioluminescence, and Others), Application (Drug Discovery, Disease Characterization, and Toxicology), Therapeutic Area (Alzheimer's Disease, Parkinson's Disease, Oncology, and Other Therapeutic Areas), Biological Variable (BOLD, Oxygenation, Blood Flow, Microvessels, Neuronal Activity, and Soft Tissue), Temporal Format of Use (Under an Hour, Many Hours, and Longitudinal) End User (Pharma-Inhouse, CRO, Academia, and Others), Country (South Africa, Saudi Arabia, U.A.E., Egypt, Israel, and Rest of Middle East and Africa) - Industry Trends and Forecast to 2030.

Overview of Middle East and Africa In Vivo Preclinical Brain Imaging Devices Market Dynamics

Driver
Rising prevalence of neurological disorder
Restraint
Ethical and regulatory consideration
Opportunity
Rising research and development activities

Market Players

The key market players operating in the Middle East and Africa in vivo preclinical brain imaging devices market are:

Bruker
PerkinElmer Inc.
FUJIFILM Corporation
Miltenyi Biotec
Charles River Laboratories.
Hologic, Inc.
LI-COR, Inc.
MILabs B.V.
TriFoil Imaging
Berthold Technologies GmbH & Co.KG
A14R
Aspect Imaging Ltd.
Cubresa Inc.
Mediso Ltd.
MR Solutions
Spectrum Instruments Imaging

1 INTRODUCTION 14

1.1 OBJECTIVES OF THE STUDY 14
1.2 MARKET DEFINITION 14
1.3 OVERVIEW OF THE MIDDLE EAST AND AFRICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET 14
1.4 CURRENCY AND PRICING 15
1.5 LIMITATIONS 16
1.6 MARKETS COVERED 16

2 MARKET SEGMENTATION 18

2.1 MARKETS COVERED 18
2.2 GEOGRAPHICAL SCOPE 19
2.3 YEARS CONSIDERED FOR THE STUDY 20
2.4 DBMR TRIPOD DATA VALIDATION MODEL 21
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 24
2.6 MULTIVARIATE MODELLING 25
2.7 IMAGING MODALITY TYPE SEGMENT LIFELINE CURVE 25
2.8 MARKET END USER COVERAGE GRID 26
2.9 DBMR MARKET POSITION GRID 27
2.10 VENDOR SHARE ANALYSIS 29
2.11 SECONDARY SOURCES 30
2.12 ASSUMPTIONS 30

3 EXECUTIVE SUMMARY 31

4 PREMIUM INSIGHTS 34

4.1 PESTEL ANALYSIS 35
4.2 PORTR'S FIVE FORCES 36

5 REGULATORY FRAMEWORK 37

5.1 REGULATORY SCENARIO IN U.S. 37
5.2 REGULATORY SCENARIO IN AUSTRALIA 37
5.3 REGULATORY SCENARIO IN EUROPE 38
5.4 REGULATORY SCENARIO IN SOUTH AFRICA 38
5.5 REGULATORY SCENARIO IN BRAZIL 38

6 MARKET OVERVIEW 39

6.1 DRIVERS 41
- 6.1.1 RISING PREVALENCE OF NEUROLOGICAL DISORDERS 41
- 6.1.2 ADVANCEMENTS IN IMAGING TECHNIQUES USED IN BRAIN IMAGING 41
- 6.1.3 INCREASING ADOPTION OF IN-VIVO IMAGING SYSTEMS 42
6.2 RESTRAINTS 42
- 6.2.1 ETHICAL AND REGULATORY CONSIDERATIONS 42
- 6.2.2 HIGH COST ASSOCIATED WITH BRAIN IMAGING EQUIPMENT 42
6.3 OPPORTUNITIES 43
- 6.3.1 RISING STRATEGIC INITIATIVES BY THE KEY MARKET PLAYERS 43
- 6.3.2 RISING RESEARCH AND DEVELOPMENT ACTIVITIES 43
6.4 CHALLENGES 44
- 6.4.1 LACK OF SKILLED PROFESSIONALS DUE TO TECHNOLOGY ADVANCEMENT 44
- 6.4.2 INTEGRATION OF IMAGING DEVICES WITH OTHER TECHNOLOGIES 45

7 MIDDLE EAST AND AFRICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE 46

7.1 OVERVIEW 47
7.2 MRI 48
7.3 PET/SPECT 49
7.4 CT 49
7.5 OPTICAL MINISCOPES 50
7.6 2 PHOTON CONFOCAL 50
7.7 US 51
7.8 NIR FLUORESCENCE 51
7.9 OCT 52
7.10 BIOLUMINESCENCE 52
7.11 OTHERS 53

8 MIDDLE EAST AND AFRICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION 54

8.1 OVERVIEW 55
8.2 DRUG DISCOVERY 56
- 8.2.1 PRECLINICAL STUDIES 57
- 8.2.2 EARLY DRUG DISCOVERY 57
- 8.2.3 CLINICAL DEVELOPMENT 57
- 8.2.4 POST MARKET MONITORING 57
- 8.2.5 DATA REVIEW 57
8.3 DISEASE CHARACTERIZATION 57
8.4 TOXICOLOGY 58

9 MIDDLE EAST AND AFRICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA 59

9.1 OVERVIEW 60
9.2 ALZHEIMER'S DISEASE 61
9.3 PARKINSON'S DISEASE 62
9.4 ONCOLOGY 62
9.5 OTHER THERAPEUTIC AREAS 63

10 MIDDLE EAST AND AFRICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 64

10.1 OVERVIEW 65
10.2 BOLD 66
10.3 OXYGENATION 67
10.4 BLOOD FLOW 67
10.5 MICROVESSELS 68
10.6 NEURONAL ACTIVITY 68
10.7 SOFT TISSUE 69

11 MIDDLE EAST AND AFRICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE 70

11.1 OVERVIEW 71
11.2 UNDER AN HOUR 72
11.3 MANY HOURS 73
11.4 LONGITUDINAL 73

12 MIDDLE EAST AND AFRICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER 74

12.1 OVERVIEW 75
12.2 PHARMA-INHOUSE 76
12.3 CRO 77
12.4 ACADEMIA 77
12.5 OTHERS 78

13 MIDDLE EAST AND AFRICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION 79

13.1 MIDDLE EAST AND AFRICA 80

14 MIDDLE EAST AND AFRICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, COMPANY LANDSCAPE 94

14.1 COMPANY SHARE ANALYSIS: MIDDLE EAST AND AFRICA 94

15 SWOT ANALYSIS 95

16 COMPANY PROFILE 96

16.1 BRUKER 96
- 16.1.1 COMPANY SNAPSHOT 96
- 16.1.2 REVENUE ANALYSIS 96
- 16.1.3 COMPANY SHARE ANALYSIS 97
- 16.1.4 PRODUCT PORTFOLIO 97
- 16.1.5 RECENT DEVELOPMENT 97
16.2 PERKINELMER INC. 98
- 16.2.1 COMPANY SNAPSHOT 98
- 16.2.2 REVENUE ANALYSIS 98
- 16.2.3 COMPANY SHARE ANALYSIS 99
- 16.2.4 PRODUCT PORTFOLIO 99
- 16.2.5 RECENT DEVELOPMENT 99
16.3 FUJIFILM CORPORATION 100
- 16.3.1 COMPANY SNAPSHOT 100
- 16.3.2 REVENUE ANALYSIS 100
- 16.3.3 COMPANY SHARE ANALYSIS 101
- 16.3.4 PRODUCT PORTFOLIO 101
- 16.3.5 RECENT DEVELOPMENT 101
16.4 MILTENYI BIOTEC 102
- 16.4.1 COMPANY SNAPSHOT 102
- 16.4.2 COMPANY SHARE ANALYSIS 102
- 16.4.3 PRODUCT PORTFOLIO 103
- 16.4.4 RECENT DEVELOPMENT 103
16.5 CHARLES RIVER LABORATORIES. 104
- 16.5.1 COMPANY SNAPSHOT 104
- 16.5.2 REVENUE ANALYSIS 104
- 16.5.3 COMPANY SHARE ANALYSIS 105
- 16.5.4 PRODUCT PORTFOLIO 105
- 16.5.5 RECENT DEVELOPMENT 105
16.6 AI4R 106
- 16.6.1 COMPANY SNAPSHOT 106
- 16.6.2 PRODUCT PORTFOLIO 106
- 16.6.3 RECENT DEVELOPMENT 106
16.7 ASPECT IMAGING LTD. 107
- 16.7.1 COMPANY SNAPSHOT 107
- 16.7.2 PRODUCT PORTFOLIO 107
- 16.7.3 RECENT DEVELOPMENT 107
16.8 BERTHOLD TECHNOLOGIES GMBH & CO.KG 108
- 16.8.1 COMPANY SNAPSHOT 108
- 16.8.2 PRODUCT PORTFOLIO 108
- 16.8.3 RECENT DEVELOPMENT 108
16.9 CUBRESA INC. 109
- 16.9.1 COMPANY SNAPSHOT 109
- 16.9.2 PRODUCT PORTFOLIO 109
- 16.9.3 RECENT DEVELOPMENT 109
16.10 HOLOGIC, INC. 110
- 16.10.1 COMPANY SNAPSHOT 110
- 16.10.2 REVENUE ANALYSIS 110
- 16.10.3 PRODUCT PORTFOLIO 111
- 16.10.4 RECENT DEVELOPMENT 111
16.11 LI-COR, INC. 112
- 16.11.1 COMPANY SNAPSHOT 112
- 16.11.2 PRODUCT PORTFOLIO 112
- 16.11.3 RECENT DEVELOPMENT 112
16.12 MEDISO LTD. 113
- 16.12.1 COMPANY SNAPSHOT 113
- 16.12.2 PRODUCT PORTFOLIO 113
- 16.12.3 RECENT DEVELOPMENT 113
16.13 MILABS B.V. 114
- 16.13.1 COMPANY SNAPSHOT 114
- 16.13.2 PRODUCT PORTFOLIO 114
- 16.13.3 RECENT DEVELOPMENT 114
16.14 MR SOLUTIONS 115
- 16.14.1 COMPANY SNAPSHOT 115
- 16.14.2 PRODUCT PORTFOLIO 115
- 16.14.3 RECENT DEVELOPMENT 115
16.15 SPECTRAL INSTRUMENTS IMAGING 116
- 16.15.1 COMPANY SNAPSHOT 116
- 16.15.2 PRODUCT PORTFOLIO 116
- 16.15.3 RECENT DEVELOPMENT 116
16.16 TRIFOIL IMAGING 117
- 16.16.1 COMPANY SNAPSHOT 117
- 16.16.2 PRODUCT PORTFOLIO 117
- 16.16.3 RECENT DEVELOPMENT 117

17 QUESTIONNAIRE 118

18 RELATED REPORTS 121

LIST OF TABLES

TABLE 1 MIDDLE EAST AND AFRICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND) 48
TABLE 2 MIDDLE EAST AND AFRICA MRI IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 48
TABLE 3 MIDDLE EAST AND AFRICA PET/SPECT IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 49
TABLE 4 MIDDLE EAST AND AFRICA CT IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 49
TABLE 5 MIDDLE EAST AND AFRICA OPTICAL MINISCOPES IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 50
TABLE 6 MIDDLE EAST AND AFRICA 2 PHOTON CONFOCAL IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 50
TABLE 7 MIDDLE EAST AND AFRICA US IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 51
TABLE 8 MIDDLE EAST AND AFRICA NIR FLUORESCENCE IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 51
TABLE 9 MIDDLE EAST AND AFRICA OCT IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 52
TABLE 10 MIDDLE EAST AND AFRICA BIOLUMINESCENCE IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 52
TABLE 11 MIDDLE EAST AND AFRICA OTHERS IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 53
TABLE 12 MIDDLE EAST AND AFRICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 56
TABLE 13 MIDDLE EAST AND AFRICA DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 56
TABLE 14 MIDDLE EAST AND AFRICA DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 56
TABLE 15 MIDDLE EAST AND AFRICA DISEASE CHARACTERIZATION IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 57
TABLE 16 MIDDLE EAST AND AFRICA TOXICOLOGY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 58
TABLE 17 MIDDLE EAST AND AFRICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND) 61
TABLE 18 MIDDLE EAST AND AFRICA ALZHEIMER'S DISEASE IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 61
TABLE 19 MIDDLE EAST AND AFRICA PARKINSON'S DISEASE IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 62
TABLE 20 MIDDLE EAST AND AFRICA ONCOLOGY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 62
TABLE 21 MIDDLE EAST AND AFRICA OTHER THERAPEUTIC AREAS IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 63
TABLE 22 MIDDLE EAST AND AFRICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE, 2021-2030 (USD THOUSAND) 66
TABLE 23 MIDDLE EAST AND AFRICA BOLD IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 66
TABLE 24 MIDDLE EAST AND AFRICA OXYGENATION IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 67
TABLE 25 MIDDLE EAST AND AFRICA BLOOD FLOW IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 67
TABLE 26 MIDDLE EAST AND AFRICA MICROVESSELS IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 68
TABLE 27 MIDDLE EAST AND AFRICA NEURONAL ACTIVITY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 68
TABLE 28 MIDDLE EAST AND AFRICA SOFT TISSUE IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 69
TABLE 29 MIDDLE EAST AND AFRICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND) 72
TABLE 30 MIDDLE EAST AND AFRICA UNDER AN HOUR IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 72
TABLE 31 MIDDLE EAST AND AFRICA MANY HOURS IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 73
TABLE 32 MIDDLE EAST AND AFRICA LONGITUDINAL IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 73
TABLE 33 MIDDLE EAST AND AFRICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND) 76
TABLE 34 MIDDLE EAST AND AFRICA PHARMA-INHOUSE IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 76
TABLE 35 MIDDLE EAST AND AFRICA CRO IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 77
TABLE 36 MIDDLE EAST AND AFRICA ACADEMIA IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 77
TABLE 37 MIDDLE EAST AND AFRICA OTHERS IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 78
TABLE 38 MIDDLE EAST AND AFRICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY COUNTRY, 2021-2030 (USD THOUSAND) 80
TABLE 39 MIDDLE EAST AND AFRICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND) 80
TABLE 40 MIDDLE EAST AND AFRICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 81
TABLE 41 MIDDLE EAST AND AFRICA DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 81
TABLE 42 MIDDLE EAST AND AFRICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND) 81
TABLE 43 MIDDLE EAST AND AFRICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND) 81
TABLE 44 MIDDLE EAST AND AFRICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND) 82
TABLE 45 MIDDLE EAST AND AFRICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND) 82
TABLE 46 SOUTH AFRICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND) 83
TABLE 47 SOUTH AFRICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 83
TABLE 48 SOUTH AFRICA DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 83
TABLE 49 SOUTH AFRICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND) 84
TABLE 50 SOUTH AFRICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND) 84
TABLE 51 SOUTH AFRICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND) 84
TABLE 52 SOUTH AFRICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND) 84
TABLE 53 SAUDI ARABIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND) 85
TABLE 54 SAUDI ARABIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 85
TABLE 55 SAUDI ARABIA DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 85
TABLE 56 SAUDI ARABIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND) 86
TABLE 57 SAUDI ARABIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND) 86
TABLE 58 SAUDI ARABIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND) 86
TABLE 59 SAUDI ARABIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND) 86
TABLE 60 U.A.E. IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND) 87
TABLE 61 U.A.E. IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 87
TABLE 62 U.A.E. DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 87
TABLE 63 U.A.E. IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND) 88
TABLE 64 U.A.E. IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND) 88
TABLE 65 U.A.E. IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND) 88
TABLE 66 U.A.E. IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND) 88
TABLE 67 EGYPT IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND) 89
TABLE 68 EGYPT IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 89
TABLE 69 EGYPT DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 89
TABLE 70 EGYPT IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND) 90
TABLE 71 EGYPT IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND) 90
TABLE 72 EGYPT IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND) 90
TABLE 73 EGYPT IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND) 90
TABLE 74 ISRAEL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND) 91
TABLE 75 ISRAEL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 91
TABLE 76 ISRAEL DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 91
TABLE 77 ISRAEL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND) 92
TABLE 78 ISRAEL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND) 92
TABLE 79 ISRAEL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND) 92
TABLE 80 ISRAEL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND) 92
TABLE 81 REST OF MIDDLE EAST AND AFRICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND) 93

LIST OF FIGURES

FIGURE 1 MIDDLE EAST AND AFRICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: SEGMENTATION 18
FIGURE 2 MIDDLE EAST AND AFRICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: DATA TRIANGULATION 21
FIGURE 3 MIDDLE EAST AND AFRICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: DROC ANALYSIS 22
FIGURE 4 MIDDLE EAST AND AFRICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: MIDDLE EAST AND AFRICA VS REGIONAL MARKET ANALYSIS 23
FIGURE 5 MIDDLE EAST AND AFRICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: COMPANY RESEARCH ANALYSIS 23
FIGURE 6 MIDDLE EAST AND AFRICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: INTERVIEW DEMOGRAPHICS 24
FIGURE 7 MIDDLE EAST AND AFRICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: MARKET END USERS COVERAGE GRID 26
FIGURE 8 MIDDLE EAST AND AFRICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: DBMR MARKET POSITION GRID 27
FIGURE 9 MIDDLE EAST AND AFRICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: VENDOR SHARE ANALYSIS 29
FIGURE 10 MIDDLE EAST AND AFRICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: SEGMENTATION 33
FIGURE 11 RISING PREVALENCE OF NEUROLOGICAL DISORDER IS EXPECTED TO DRIVE THE GROWTH OF THE MIDDLE EAST AND AFRICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET FROM 2023 TO 2030 34
FIGURE 12 IMAGING MODALITY TYPE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST AND AFRICA VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET IN 2023 & 2030 34
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE MIDDLE EAST AND AFRICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET 40
FIGURE 14 MIDDLE EAST AND AFRICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: BY IMAGING MODALITY TYPE, 2022 47
FIGURE 15 MIDDLE EAST AND AFRICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: BY APPLICATION, 2022 55
FIGURE 16 MIDDLE EAST AND AFRICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: BY THERAPEUTIC AREA, 2022 60
FIGURE 17 MIDDLE EAST AND AFRICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: BY BIOLOGICAL VARIABLE, 2022 65
FIGURE 18 MIDDLE EAST AND AFRICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: BY TEMPORAL FORMAT OF USE, 2022 71
FIGURE 19 MIDDLE EAST AND AFRICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: BY END USER, 2022 75
FIGURE 20 MIDDLE EAST AND AFRICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: COMPANY SHARE 2022 (%) 94